Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.26355/eurrev_202101_24428 http://scihub22266oqcxt.onion/10.26355/eurrev_202101_24428 33506949!ä!33506949 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Rev+Med+Pharmacol+Sci 2021 ; 25 (1): 556-566 Nephropedia Template TP {{tp|p=33506949|t=2021. Quinacrine as a potential treatment for COVID-19 virus infection |pdf=|usr=}}{{33506949}} gab.com Text Quinacrine as a potential treatment for COVID-19 virus infection JO: Eur Rev Med Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33506949 #FOAvip A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a current outbreak of infection termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 is currently a global pandemic that may cause close to half a billion deaths around the world. Until now, there is no effective treatment for COVID-19. Quinacrine (Qx) has been used since the 1930s as preventive antimalarial compound. It is a recognized small molecule inhibitor of RNA virus replication, with known anti-prion activity, and identified as a potent Ebola virus inhibitor both in vitro and in vivo. Recently, Qx has showed anti-SARS-CoV-2 activity. Herein, we review the potential mechanisms associated with quinacrine as an antiviral compound. Twit Text FOAVip Quinacrine as a potential treatment for COVID-19 virus infection ????Eur Rev Med Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33506949 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33506949 #FOAvip English Wikipedia <ref>{{Cite pmid|33506949}}</ref> Quinacrine as a potential treatment for COVID-19 virus infection #MMPMID33506949 Pineda B; Perez de la Cruz V; Hernandez Pando R; Sotelo J Eur Rev Med Pharmacol Sci 2021[Jan]; 25 (1): 556-566 PMID33506949show ga A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a current outbreak of infection termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 is currently a global pandemic that may cause close to half a billion deaths around the world. Until now, there is no effective treatment for COVID-19. Quinacrine (Qx) has been used since the 1930s as preventive antimalarial compound. It is a recognized small molecule inhibitor of RNA virus replication, with known anti-prion activity, and identified as a potent Ebola virus inhibitor both in vitro and in vivo. Recently, Qx has showed anti-SARS-CoV-2 activity. Herein, we review the potential mechanisms associated with quinacrine as an antiviral compound. |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2/drug effects[MESH] |Animals[MESH] |Antiviral Agents/administration & dosage/adverse effects/*pharmacology[MESH] |COVID-19/immunology[MESH] |Cell Line[MESH] |Cytokine Release Syndrome/immunology/prevention & control[MESH] |Cytokines/immunology[MESH] |Humans[MESH] |Mice[MESH] |Quinacrine/administration & dosage/adverse effects/*pharmacology[MESH]Quinacrine as a potential treatment for COVID-19 virus infection (epmc).pdf DeepDyve Pubget Overpricing